openPR Logo
Press release

Global Pulmonary Drug Delivery Devices Industry 2018 Global Market Size, Technology Review, Cost Analysis and Demand Overview

04-05-2019 01:01 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Infinium Global Research

/ PR Agency: Infinium Global Research
Pulmonary Drug Delivery Devices Industry

Pulmonary Drug Delivery Devices Industry

We have produced a new premium report Pulmonary Drug Delivery Devices Market. The report covers the analysis of global as well as regional markets of Pulmonary Drug Delivery Devices. The objective of the study is to identify market sizes of different segments & countries in recent years and to forecast the values for the next six years. The report also deep dives into the sub-segments of Pulmonary Drug Delivery Devices Market by product type (metered dose inhaler, dry powder inhaler and nebuliser), application (asthma, COPD, cystic fibrosis and others) and distribution channel (hospital pharmacies, retail pharmacy stores and others) through main geographies in the Global Market such as North America, Europe, Asia-Pacific and RoW.

The report covers market changing aspects including drivers, restraints, opportunities, and trends expected to encourage the expansion of the Pulmonary Drug Delivery Devices Market during the said period. The report also provides market attractiveness analysis, by geography, and market share analysis, by key players respectively. Some of the prominent participants in the Global Pulmonary Drug Delivery Devices Market are Teva Pharmaceutical Industries Ltd, AstraZeneca Plc, GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Merck & Co., Inc., Novartis AG, Omron Corporation, Sunovion Pharmaceuticals Inc., GF Health Products, Inc., and 3M Healthcare.

Get Free Sample pages of this Report@ https://www.infiniumglobalresearch.com/reports/sample-request/1361

North America to influence the global pulmonary drug delivery devices market through 2018-2024

The global pulmonary drug delivery devices market has been dominated by the North America region over the historic period 2015-16 followed by Europe. An increasing number of patients affected with lungs disorder coupled with developed healthcare infrastructure are the key factors responsible for driving the growth of pulmonary drug delivery devices market in this region. Also rising geriatric population in the U.S to augment the growth of the market in this region.

Asia Pacific region is expected to be the fastest growing region on account of developing healthcare infrastructure, increased spending on healthcare in developing countries like India, China, and other South East Asian countries.

Presence of Large Patient Pool affected with the respiratory disorder to fuel the pulmonary drug delivery devices market.

A large number of populations are affected with respiratory disorders that include COPD, bronchitis, emphysema, interstitial lung diseases, tumors of the lung, pulmonary embolism, asthma, and related disorders. Pulmonary asthma and cystic fibrosis are the most common form of lungs disorders found among the global population. Thus increasing presence of large patient pool with a respiratory disorder is expected to fuel the pulmonary drug delivery devices market. Besides this, increasing technological developments in the form of smart/digital inhalers, an increasing number of smokers, and growth of the distribution network will also drive the demand for the pulmonary drug devices.

Introduction of metered dose inhalers can create huge growth opportunities in the near future

Metered dose inhalers deliver a specific amount of medication to the lungs, in the form of a short burst of aerosolized medicine. Some MDI’s provide on-screen instruction to the users. MDIs can be further classified into three categories based on the drugs delivered, namely metered dose inhalers with bronchodilators, corticosteroids, and a combination of both. These are still not been widely adopted, increased adoption of MDI can thus create huge growth opportunities for pulmonary drug delivery devices. Furthermore, digitizing pulmonary drug delivery devices can escalate better growth opportunities.

Leading companies focusing on digitizing pulmonary drug delivery devices

Some of the prominent companies in the manufacturing of pulmonary drug delivery devices include Teva Pharmaceutical Industries Ltd, AstraZeneca Plc, GlaxoSmithKline Plc, Boehringer Ingelheim GmbH, Merck & Co., Inc., Novartis AG, Omron Corporation, Sunovion Pharmaceuticals Inc., GF Health Products, Inc. and 3M Healthcare. These companies are focusing on developing innovative drug delivery devices that can be connected to the smartphones and provides feedback to the patient and health care provider via a mobile app.

Browse Detailed TOC, Description, and Companies Mentioned in Report @ https://www.infiniumglobalresearch.com/healthcare-medical-devices/global-pulmonary-drug-delivery-devices-market

Report Highlights:

The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global pulmonary drug delivery devices market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of pulmonary drug delivery devices market. Moreover, the study highlights current market trends and provides forecast from 2018-2024. We also have highlighted future trends in the pulmonary drug delivery devices market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. This report will help manufacturers, suppliers and distributors of the pulmonary drug delivery devices market to understand the present and future trends in this market and formulate their strategies accordingly.

Infinium Global Research and Consulting Solutions is started with a single motto of being a business partner of the first choice. We at Infinium work on the strengths of our clients to ensure we help them consolidate their market position. We firmly believe in the fact that ‘if you are able to develop newer opportunities then you find there is no dearth of opportunities for you. With our strategic research approaches and deep dive in the market segments, we try to find out new opportunities that our clients can encash with their existing resources. Our experts with over 100 years of cumulative experience in research offer the best in the industry services to our clients to ensure that they achieve their business goals.

Infinium Global Research
Office No. 04, 06, Ganadhish Empire,
Rahatani Corner, Pune, MH 411027
Email: info@infiniumglobalresearch.com
Website: www.infiniumglobalresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Pulmonary Drug Delivery Devices Industry 2018 Global Market Size, Technology Review, Cost Analysis and Demand Overview here

News-ID: 1690555 • Views:

More Releases from Infinium Global Research

Sustainable Aviation Fuel (SAF) Market Growth Outlook Strong with USD 5000 Million Valuation by 2028
Sustainable Aviation Fuel (SAF) Market Growth Outlook Strong with USD 5000 Milli …
The global sustainable aviation fuel (SAF) market is witnessing an unprecedented surge, growing from nearly USD 290 million in 2022 to over USD 5,000 million by 2028, at a remarkable CAGR of more than 60%. This rapid expansion highlights the industry's strong commitment to decarbonizing aviation, which remains one of the most carbon-intensive transportation sectors. SAF, produced from renewable resources such as waste oils, agricultural residues, municipal waste, and biomass,
Automotive Windshield Market Size to Expand from USD 17.49 Bn in 2023 to USD 30.84 Bn in 2032
Automotive Windshield Market Size to Expand from USD 17.49 Bn in 2023 to USD 30. …
The global automotive windshield market is one of the most essential components of the automotive industry, ensuring both passenger safety and driver visibility. Valued at USD 17.49 billion in 2023, the market is projected to reach USD 30.84 billion by 2032, expanding at a CAGR of 6.53% from 2024 to 2032. Windshields are no longer just protective glass panels; they have evolved into high-performance safety components incorporating advanced technologies such
Satellite Communication Equipment Market Poised for USD 44 Bn by 2032
Satellite Communication Equipment Market Poised for USD 44 Bn by 2032
The global satellite communication (SATCOM) equipment market is undergoing rapid expansion, fueled by the increasing need for reliable connectivity across diverse applications. Valued at approximately USD 20 billion in 2023, the market is forecasted to nearly double, reaching USD 44 billion by 2032, registering a CAGR of almost 10% during 2024-2032. SATCOM equipment, comprising receivers, antennas, transponders, and transceivers, plays a critical role in enabling long-distance communication for both commercial
Solar Vehicle Market Growth Outlook Strong with USD 6.25B Valuation by 2032
Solar Vehicle Market Growth Outlook Strong with USD 6.25B Valuation by 2032
The global solar vehicle market is rapidly emerging as one of the most promising segments in sustainable mobility. Valued at USD 331.68 million in 2023, the market is expected to surge to USD 6,255.20 million by 2032, expanding at an impressive CAGR of 38.63% from 2024 to 2032. This unprecedented growth reflects the convergence of rising environmental concerns, government initiatives, and technological breakthroughs in solar panel and battery efficiency. Solar

All 5 Releases


More Releases for Pulmonary

Chronic Pulmonary Aspergillosis Drugs Market - Revitalizing Lungs: Revolutionary …
Newark, New Castle, USA - new report, titled Chronic Pulmonary Aspergillosis Drugs Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Chronic Pulmonary Aspergillosis Drugs market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Chronic Pulmonary Aspergillosis Drugs market. The report offers
Global Pulmonary Embolism Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Pulmonary Embolism Market is exhibited at USD 1.59 billion in 2023 and is projected to surpass USD 3.15 billion in 2028, anticipated to grow at a CAGR of 8.4% from 2023 to 2028. The rapid increase in the prevalence of cancer, increasing investment for healthcare infrastructure and rising research and development activities, high disposable income, rising demand
Global Pulmonary Arterial Hypertension Market Size
According to a new market research report published by Global Market Estimates, the Global Pulmonary Arterial Hypertension Market is projected to grow at a CAGR of 5.2% from 2022 to 2027. Congenital heart diseases and other ailments such as HIV infection, chronic liver disease (cirrhosis), and connective tissue disorders (scleroderma, lupus, and others) are fueling market expansion. Browse 153 Market Data Tables and 113 Figures spread through 185 Pages and in-depth TOC
New Study: Pulmonary Drugs Market Report
The pulmonary drugs market is expected to witness unprecedented growth in the near future, thanks to large number of approvals from the FDA. The FDA approved a large number of pulmonary drugs for major illnesses like small-cell lung cancer, tuberculosis, and pneumonia over the past few years. Additionally, newly approved drugs also treat newly found diseases like obstructive sleep apnea. These approvals are in line with the recent trend of
Pulmonary Drugs Market Forecast till 2025
Pulmonary Drugs Market – Boon for Diseased Lungs Pulmonary drugs can treat wide range of conditions, which are included within the ambit of pulmonary diseases such as pneumonia, allergic rhinitis, pulmonary hypertension, and others. . Pulmonary drugs provide medications for all types of pulmonary diseases, which is expected to fuel market growth in near future. The World Health Organization (WHO) states that most respiratory diseases are preventable and can be treated
03-15-2017 | Health & Medicine
TMR
Pulmonary Drug Delivery Devices Market: Demand for Pulmonary Drug Delivery Devic …
This report on pulmonary drug delivery devices studies the current as well as future prospects of the market globally. The stakeholders of this report include companies and intermediaries engaged in the manufacture and commercialization of various pulmonary/respiratory drugs and/or drug-device combinations as well as new entrants planning to enter this market. This report comprises an elaborate executive summary along with a market snapshot providing overall information of various segments and sub-segments